Our business is breakthroughs

We take cutting-edge innovations from the lab bench to the bedside, translating them into effective tools, treatments and diagnostics for people with cancer.

 

Find out more
Scientist working in a lab

14

marketed drugs

£600m+

revenue from royalties and IP

150+

active licences

79

start-ups

£3bn+

raised by our start-up portfolio

Innovate and work with us

Image of a smiling scientist

Researchers

We support innovative research that can benefit society. Let us help you turn your ideas into meaningful progress for patients.

A person sat at a desk, short hair, glasses and short sleeved shirt wearing a lanyard, looking at the person next to them

Partners

We de-risk innovation by turning promising science into high-value assets. Partner with us for access to our extensive network and portfolio.

Investors image

Investors

We invest and co-invest in societal progress, and in the people who can turn ideas into a business reality. Explore investment opportunities with us.

The cover of our latest annual review being held by two hands. The text on the cover reads 'Annual review 2023/24' and shows a photo of two researchers walking down a corridor.

Our 2023-2024 annual review is out now

See our key milestones and discover the latest innovations, start-ups, and projects set to transform the oncology sector and improve the lives of those affected by cancer. 

Read the review
FGC scientists in the lab

Drug discovery and development capabilities

Spotlight

We're committed to driving therapeutic innovation in oncology, with six drug discovery sites and one focus: accelerating the discovery and development of new therapeutics. Our expertise spans target identification, validation and clinical positioning, through Hit identification and lead optimisation to the selection of candidate drugs for regulatory development, for both small molecule and antibody modalities.

Through partnership with the Cancer Research UK Centre for Drug Development we can also offer access to the capabilities and infrastructure needed to demonstrate clinical potential.

Explore our capabilities

Our portfolio

Scientist with a beard using a pipette

Explore our pipeline

We've played a role in delivering 13 new cancer treatments for patients. Explore our clinical and preclinical assets currently in development.

A woman sitting in front of a laptop

Licensing opportunities

Discover the innovations we have available for collaboration, that will help create the medicines of tomorrow.

Three people in discussion sat at a table

Our start-up portfolio

With a growing portfolio of start-ups, we're bringing together the community to spark the next breakthrough in cancer research.